StreetInsider.com News Articles

Retractable Technologies, Inc. Supports Senator Blackburn’s ONSHORE Manufacturing Act

Thu, 03 Sep 2026 17:25:00 -0400

LITTLE ELM, Texas--(BUSINESS WIRE)-- Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announces its support for Senator Marsha Blackburn’s ONSHORE Manufacturing Act, legislation aimed at strengthening domestic production of critical medical supplies.

The legislation would provide tax incentives for U.S. manufacturing, including investments in advanced manufacturing equipment and facility modernization.

“The ONSHORE Manufacturing Act is the spark American manufacturers need to rebuild our domestic medical base. This legislation ensures that healthcare providers have uninterrupted access to safe, American-made medical products. We are proud to support Senator Blackburn’s efforts in safeguarding our public health infrastructure,” said Sarah Umandap, Government and Public

Retractable Technologies, Inc. Supports Senator Blackburn’s ONSHORE Manufacturing Act

Thu, 03 Sep 2026 17:25:00 -0400

The legislation would provide tax incentives for U.S. manufacturing, including investments in advanced manufacturing equipment and facility modernization.

Form 8-K RETRACTABLE TECHNOLOGIES For: Aug 14

Fri, 14 Aug 2026 17:19:00 -0400

si-local-file:///var/storage/secattach/20260814/26932799.html

Form 8-K RETRACTABLE TECHNOLOGIES For: Aug 14

Fri, 14 Aug 2026 17:19:00 -0400

si-local-file:///var/storage/secattach/20260814/26932799.html

Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026

Fri, 14 Aug 2026 17:12:00 -0400

LITTLE ELM, Texas--(BUSINESS WIRE)-- Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.2 million for the second quarter of 2026 and an operating loss of $5.1 million for the period, as compared to total net sales for the same period last year of $10.4 million and an operating loss of $5.1 million. For the first half of the year, net sales were $14.4 million and operating losses were $11.3 million as compared to 2025 net revenues of $18.7 million and operating losses of $9.8 million.

While the majority of flu season sales typically occur in

Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026

Fri, 14 Aug 2026 17:12:00 -0400

While the majority of flu season sales typically occur in

Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026

Fri, 14 Aug 2026 17:12:00 -0400

While the majority of flu season sales typically occur in

Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026

Fri, 14 Aug 2026 17:12:00 -0400

While the majority of flu season sales typically occur in

Form 10-Q RETRACTABLE TECHNOLOGIES For: Jun 30

Fri, 14 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260814/26931326.html

Form 10-Q RETRACTABLE TECHNOLOGIES For: Jun 30

Fri, 14 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260814/26931326.html

Form 8-K RETRACTABLE TECHNOLOGIES For: Jun 30

Tue, 30 Jun 2026 12:28:00 -0400

si-local-file:///var/storage/secattach/20260630/26712192.html

Form 8-K RETRACTABLE TECHNOLOGIES For: Jun 30

Tue, 30 Jun 2026 12:28:00 -0400

si-local-file:///var/storage/secattach/20260630/26712192.html

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Tue, 30 Jun 2026 12:00:00 -0400

LITTLE ELM, Texas--(BUSINESS WIRE)-- Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning April 1, 2026 through June 30, 2026. The dividends will be paid on July 20, 2026 to shareholders of record as of the close of business on July 10, 2026.

Retractable manufactures and markets VanishPoint® and Patient Safe®

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Tue, 30 Jun 2026 12:00:00 -0400

Retractable manufactures and markets VanishPoint® and Patient Safe®

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Tue, 30 Jun 2026 12:00:00 -0400

Retractable manufactures and markets VanishPoint® and Patient Safe®

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Tue, 30 Jun 2026 12:00:00 -0400

Retractable manufactures and markets VanishPoint® and Patient Safe®

Form 8-K RETRACTABLE TECHNOLOGIES For: May 15

Fri, 15 May 2026 16:43:00 -0400

si-local-file:///var/storage/secattach/20260515/26506965.html

Form 8-K RETRACTABLE TECHNOLOGIES For: May 15

Fri, 15 May 2026 16:43:00 -0400

si-local-file:///var/storage/secattach/20260515/26506965.html

Retractable Technologies, Inc. Results for the Period Ended March 31, 2026

Fri, 15 May 2026 16:19:00 -0400

LITTLE ELM, Texas--(BUSINESS WIRE)-- Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.2 million for the first three months of 2026 and an operating loss of $6.2 million for the period, as compared to total net sales for the same period last year of $8.3 million and an operating loss of $4.7 million.

In the first quarter of 2026, a larger proportion of international sales and an increase in EasyPoint® needle sales contributed to lower overall revenues despite unit sales increasing slightly.

In the first three months of 2026, we spent less than $12 thousand on

Retractable Technologies, Inc. Results for the Period Ended March 31, 2026

Fri, 15 May 2026 16:19:00 -0400

In the first quarter of 2026, a larger proportion of international sales and an increase in EasyPoint® needle sales contributed to lower overall revenues despite unit sales increasing slightly.

In the first three months of 2026, we spent less than $12 thousand on

Retractable Technologies, Inc. Results for the Period Ended March 31, 2026

Fri, 15 May 2026 16:19:00 -0400

In the first quarter of 2026, a larger proportion of international sales and an increase in EasyPoint® needle sales contributed to lower overall revenues despite unit sales increasing slightly.

In the first three months of 2026, we spent less than $12 thousand on

Retractable Technologies, Inc. Results for the Period Ended March 31, 2026

Fri, 15 May 2026 16:19:00 -0400

In the first quarter of 2026, a larger proportion of international sales and an increase in EasyPoint® needle sales contributed to lower overall revenues despite unit sales increasing slightly.

In the first three months of 2026, we spent less than $12 thousand on

Form 10-Q RETRACTABLE TECHNOLOGIES For: Mar 31

Fri, 15 May 2026 13:35:00 -0400

si-local-file:///var/storage/secattach/20260515/26503350.html

Form 10-Q RETRACTABLE TECHNOLOGIES For: Mar 31

Fri, 15 May 2026 13:35:00 -0400

si-local-file:///var/storage/secattach/20260515/26503350.html

Form 8-K RETRACTABLE TECHNOLOGIES For: May 08

Wed, 13 May 2026 14:15:00 -0400

si-local-file:///var/storage/secattach/20260513/26485061.html